Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and includes an updated Intervention/Treatment label. The revision tag is updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check20 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a small platform/documentation update rather than changes to study details or results.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page shows a new revision label, updating from v3.5.3 to v3.5.4. This represents a small platform or page maintenance update without altering visible study content.SummaryDifference0.0%

- Check49 days agoChange DetectedEnrollment is updated to 700 participants. Primary completion is now 2027-12-01 and study completion is 2032-12-01, with related update dates 2026-04-30 and 2026-05-04.SummaryDifference0.2%

- Check63 days agoChange DetectedThe study details page has been updated to reflect a new set of participating sites, including additions of specific hospitals/centers and countries, and the total number of locations has increased (from 90 to 97). The record update date and the page revision/version have also been updated.SummaryDifference1%

- Check99 days agoChange DetectedRevision: v3.5.0 has been added, and Revision: v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.